Results 221 to 230 of about 221,459 (281)

The future of periodontology: Emerging technologies and conceptual shifts

open access: yesJournal of Periodontology, EarlyView.
Abstract Periodontology is entering a transformative era driven by advances in diagnostics, therapeutics, and digital integration. Emerging technologies and conceptual shifts are currently reshaping the specialty, with a focus on predictive, preventive, and personalized care.
Michael S. Reddy
wiley   +1 more source

Immunological and periodontal benefits of prebiotic polydextrose in rats with induced periodontitis

open access: yesJournal of Periodontology, EarlyView.
Abstract Background Prebiotic therapy is a promising approach for managing periodontitis due to its potential benefits in modulating the microbiome and the immune response. This study aimed to evaluate the effects of the prebiotic (PREB) polydextrose (PDX) on the development of experimental periodontitis (EP) in rats.
Raquel de S. F Nassar   +9 more
wiley   +1 more source

Prevalence of disorders of gut–brain‐interaction in pediatric patients with in‐remission inflammatory bowel disease: An Italian multicenter study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Pediatric patients with in‐remission inflammatory bowel disease (IBD) often report persistent gastrointestinal symptoms, suggesting a potential overlap with disorders of gut–brain‐interaction (DGBIs). While DGBIs affect up to 40% of the general population, their prevalence in quiescent IBD children remains limited.
Giovanna Quatrale   +14 more
wiley   +1 more source

Factors related to loss to follow‐up and low compliance in Helicobacter pylori‐infected children: The EuroPedHp Registry

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Factors related to loss to follow‐up and low compliance in Helicobacter pylori‐infected children. Abstract Objectives Monitoring for Helicobacter pylori (H. pylori)‐eradication is important, since symptom improvement does not indicate treatment success. Using EuroPedHp Registry data, we investigated characteristics of children missing monitoring visits
Thu Giang Le Thi   +42 more
wiley   +1 more source

Gastrointestinal manifestations following chimeric antigen receptor T‐cell (CAR‐T) 19 therapy in pediatric patients with CD19+ acute lymphoblastic leukemia

open access: yesJPGN Reports, EarlyView.
Abstract Pediatric patients with CD19+ acute lymphoblastic leukemia (ALL) undergoing chimeric antigen receptor T‐cell (CAR‐T) therapy frequently experience gastrointestinal (GI) complications. A retrospective study analyzed 13 patients (median age: 8 years) treated between January 2020 and January 2024.
Judith Raya Muñoz   +8 more
wiley   +1 more source

T-Cell Populations in Infancy After Maternal Probiotic Supplementation to Prevent Atopic Dermatitis. [PDF]

open access: yesClin Transl Allergy
Zakiudin DP   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy